ID   UBP19_RAT               Reviewed;        1357 AA.
AC   Q6J1Y9;
DT   10-JUL-2007, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2004, sequence version 1.
DT   24-JUL-2024, entry version 111.
DE   RecName: Full=Ubiquitin carboxyl-terminal hydrolase 19;
DE            EC=3.4.19.12;
DE   AltName: Full=Deubiquitinating enzyme 19;
DE   AltName: Full=Ubiquitin thioesterase 19;
DE   AltName: Full=Ubiquitin-specific-processing protease 19;
GN   Name=Usp19;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY, AND INDUCTION.
RC   STRAIN=Sprague-Dawley; TISSUE=Testis;
RX   PubMed=15562254; DOI=10.1152/ajpendo.00281.2004;
RA   Combaret L., Adegoke O.A.J., Bedard N., Baracos V., Attaix D., Wing S.S.;
RT   "USP19 is a ubiquitin-specific protease regulated in rat skeletal muscle
RT   during catabolic states.";
RL   Am. J. Physiol. 288:E693-E700(2005).
RN   [2]
RP   PROTEIN SEQUENCE OF 2-11; 60-76 AND 837-845, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RC   STRAIN=Sprague-Dawley; TISSUE=Brain;
RA   Lubec G., Kang S.U., Lubec S.;
RL   Submitted (SEP-2007) to UniProtKB.
RN   [3]
RP   FUNCTION.
RX   PubMed=19773579; DOI=10.1152/ajpendo.00409.2009;
RA   Sundaram P., Pang Z., Miao M., Yu L., Wing S.S.;
RT   "USP19-deubiquitinating enzyme regulates levels of major myofibrillar
RT   proteins in L6 muscle cells.";
RL   Am. J. Physiol. 297:E1283-E1290(2009).
RN   [4]
RP   FUNCTION, SUBCELLULAR LOCATION, INTERACTION WITH RNF123, AND MUTAGENESIS OF
RP   CYS-545.
RX   PubMed=19015242; DOI=10.1128/mcb.00329-08;
RA   Lu Y., Adegoke O.A.J., Nepveu A., Nakayama K.I., Bedard N., Cheng D.,
RA   Peng J., Wing S.S.;
RT   "USP19 deubiquitinating enzyme supports cell proliferation by stabilizing
RT   KPC1, a ubiquitin ligase for p27Kip1.";
RL   Mol. Cell. Biol. 29:547-558(2009).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-283, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Deubiquitinating enzyme that regulates the degradation of
CC       various proteins. Deubiquitinates and prevents proteasomal degradation
CC       of RNF123 which in turn stimulates CDKN1B ubiquitin-dependent
CC       degradation thereby playing a role in cell proliferation. Involved in
CC       decreased protein synthesis in atrophying skeletal muscle. Modulates
CC       transcription of major myofibrillar proteins. Also involved in turnover
CC       of endoplasmic-reticulum-associated degradation (ERAD) substrates.
CC       Regulates the stability of BIRC2/c-IAP1 and BIRC3/c-IAP2 by preventing
CC       thier ubiquitination. Required for cells to mount an appropriate
CC       response to hypoxia and rescues HIF1A from degradation in a non-
CC       catalytic manner. Plays an important role in 17 beta-estradiol (E2)-
CC       inhibited myogenesis. Decreases the levels of ubiquitinated proteins
CC       during skeletal muscle formation and acts to repress myogenesis.
CC       Exhibits a preference towards 'Lys-63'-linked ubiquitin chains (By
CC       similarity). {ECO:0000250, ECO:0000269|PubMed:19015242,
CC       ECO:0000269|PubMed:19773579}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=Thiol-dependent hydrolysis of ester, thioester, amide, peptide
CC         and isopeptide bonds formed by the C-terminal Gly of ubiquitin (a 76-
CC         residue protein attached to proteins as an intracellular targeting
CC         signal).; EC=3.4.19.12;
CC   -!- SUBUNIT: Interacts with and stabilizes RNF123. Interacts with BIRC2/c-
CC       IAP1, BIRC3/c-IAP2 and XIAP/BIRC4. Interacts with HIF1A (via N-
CC       terminus) (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:19015242}; Single-pass membrane protein
CC       {ECO:0000269|PubMed:19015242}.
CC   -!- TISSUE SPECIFICITY: Expressed in testis, heart, kidney and skeletal
CC       muscle. Low levels of expression are detectable in all other tissues
CC       screened. {ECO:0000269|PubMed:15562254}.
CC   -!- INDUCTION: By streptozotocin and fasting in skeletal muscle.
CC       {ECO:0000269|PubMed:15562254}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY605065; AAT35219.1; -; mRNA.
DR   RefSeq; NP_001001516.1; NM_001001516.2.
DR   AlphaFoldDB; Q6J1Y9; -.
DR   SMR; Q6J1Y9; -.
DR   STRING; 10116.ENSRNOP00000067744; -.
DR   MEROPS; C19.024; -.
DR   iPTMnet; Q6J1Y9; -.
DR   PhosphoSitePlus; Q6J1Y9; -.
DR   jPOST; Q6J1Y9; -.
DR   PaxDb; 10116-ENSRNOP00000067744; -.
DR   GeneID; 361190; -.
DR   KEGG; rno:361190; -.
DR   AGR; RGD:1303276; -.
DR   CTD; 10869; -.
DR   RGD; 1303276; Usp19.
DR   eggNOG; KOG1870; Eukaryota.
DR   InParanoid; Q6J1Y9; -.
DR   OrthoDB; 5474185at2759; -.
DR   PhylomeDB; Q6J1Y9; -.
DR   BRENDA; 3.4.19.12; 5301.
DR   Reactome; R-RNO-5689880; Ub-specific processing proteases.
DR   PRO; PR:Q6J1Y9; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005829; C:cytosol; ISO:RGD.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; ISS:UniProtKB.
DR   GO; GO:0004843; F:cysteine-type deubiquitinase activity; ISS:UniProtKB.
DR   GO; GO:0051879; F:Hsp90 protein binding; ISO:RGD.
DR   GO; GO:1990380; F:K48-linked deubiquitinase activity; ISO:RGD.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; ISO:RGD.
DR   GO; GO:0036503; P:ERAD pathway; ISS:UniProtKB.
DR   GO; GO:1901799; P:negative regulation of proteasomal protein catabolic process; ISO:RGD.
DR   GO; GO:0048642; P:negative regulation of skeletal muscle tissue development; ISS:UniProtKB.
DR   GO; GO:0090068; P:positive regulation of cell cycle process; IMP:UniProtKB.
DR   GO; GO:0016579; P:protein deubiquitination; IMP:UniProtKB.
DR   GO; GO:0050821; P:protein stabilization; ISO:RGD.
DR   GO; GO:1900037; P:regulation of cellular response to hypoxia; ISS:UniProtKB.
DR   GO; GO:1904292; P:regulation of ERAD pathway; ISO:RGD.
DR   GO; GO:0031647; P:regulation of protein stability; IDA:UniProtKB.
DR   GO; GO:0034976; P:response to endoplasmic reticulum stress; ISS:UniProtKB.
DR   CDD; cd06466; p23_CS_SGT1_like; 1.
DR   CDD; cd06463; p23_like; 1.
DR   CDD; cd02674; Peptidase_C19R; 1.
DR   Gene3D; 2.60.40.790; -; 2.
DR   Gene3D; 6.10.140.2220; -; 1.
DR   Gene3D; 3.90.70.10; Cysteine proteinases; 2.
DR   InterPro; IPR007052; CS_dom.
DR   InterPro; IPR008978; HSP20-like_chaperone.
DR   InterPro; IPR038765; Papain-like_cys_pep_sf.
DR   InterPro; IPR001394; Peptidase_C19_UCH.
DR   InterPro; IPR050185; Ub_carboxyl-term_hydrolase.
DR   InterPro; IPR018200; USP_CS.
DR   InterPro; IPR028889; USP_dom.
DR   InterPro; IPR002893; Znf_MYND.
DR   PANTHER; PTHR21646; UBIQUITIN CARBOXYL-TERMINAL HYDROLASE; 1.
DR   PANTHER; PTHR21646:SF74; UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 19; 1.
DR   Pfam; PF04969; CS; 1.
DR   Pfam; PF00443; UCH; 1.
DR   Pfam; PF16602; USP19_linker; 1.
DR   Pfam; PF01753; zf-MYND; 1.
DR   SUPFAM; SSF54001; Cysteine proteinases; 1.
DR   SUPFAM; SSF144232; HIT/MYND zinc finger-like; 1.
DR   SUPFAM; SSF49764; HSP20-like chaperones; 2.
DR   PROSITE; PS51203; CS; 2.
DR   PROSITE; PS00972; USP_1; 1.
DR   PROSITE; PS00973; USP_2; 1.
DR   PROSITE; PS50235; USP_3; 1.
DR   PROSITE; PS01360; ZF_MYND_1; 1.
DR   PROSITE; PS50865; ZF_MYND_2; 1.
PE   1: Evidence at protein level;
KW   Direct protein sequencing; Endoplasmic reticulum; Hydrolase; Membrane;
KW   Metal-binding; Phosphoprotein; Protease; Reference proteome; Repeat;
KW   Thiol protease; Transmembrane; Transmembrane helix;
KW   Ubl conjugation pathway; Zinc; Zinc-finger.
FT   CHAIN           1..1357
FT                   /note="Ubiquitin carboxyl-terminal hydrolase 19"
FT                   /id="PRO_0000295158"
FT   TOPO_DOM        1..1330
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        1331..1351
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        1352..1357
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          51..140
FT                   /note="CS 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00547"
FT   DOMAIN          321..423
FT                   /note="CS 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00547"
FT   DOMAIN          536..1253
FT                   /note="USP"
FT   ZN_FING         830..872
FT                   /note="MYND-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00134"
FT   REGION          1..52
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          162..239
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          275..296
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          432..479
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          962..981
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1259..1278
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1292..1320
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        17..52
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        172..186
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        460..477
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1302..1316
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        545
FT                   /note="Nucleophile"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU10092,
FT                   ECO:0000255|PROSITE-ProRule:PRU10093"
FT   ACT_SITE        1204
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU10092,
FT                   ECO:0000255|PROSITE-ProRule:PRU10093"
FT   BINDING         830
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00134"
FT   BINDING         833
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00134"
FT   BINDING         847
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00134"
FT   BINDING         850
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00134"
FT   BINDING         856
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00134"
FT   BINDING         860
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00134"
FT   BINDING         868
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00134"
FT   BINDING         872
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00134"
FT   MOD_RES         221
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q3UJD6"
FT   MOD_RES         283
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MUTAGEN         545
FT                   /note="C->A: Has a destabilizing effect on RNF123."
FT                   /evidence="ECO:0000269|PubMed:19015242"
SQ   SEQUENCE   1357 AA;  150302 MW;  E2CE888D61EC3C81 CRC64;
     MSAGTSATGP RRGPPGLEEA TSKKKQKDRA NQESKDGDPR RVSMPRKEPT KDELLLDWRQ
     SSDKVVVKLR VGTGPICLEE VDAAFTDTDC VVRLPDGRQW GGVFFAKIQS SCTKVQTRKG
     GLLQLALPKK VPLLTWPSLL KKPLGTQELV PGLRCQENGQ ELSPIALEPG SEPRRAKQEA
     RNQKRAQGRG EVGSGASPGA QAGPSAKRAV HLCRGPEGEG SMDGPGPQGD APSFLSDSAT
     QVEAEEQLHV PPVNPQTSLL GSEKNLALLT VEKTVSPRSD SVSPVMIRNR DPEKDDHFKE
     EMAVGADPAA LADEPESMVN LAFVKNDSYE KGPDSVVVHV YVKESRRDTS RVLFREQDFT
     LIFQTRDGNF LRLHPGCGPH TIFRWQVKLR NLIEPEQCTF CFTASRIDIC LRKRQSQRWG
     GLEAPATRVG GAKVAVPTGP TPLDSTPPGG GPLPLTGQEE ARAVEKEKPK ARSEDSGLDG
     VVARTPLEHV TPKPEPHLAS PKPTCMVPPM PHSPVSGDSV EEDEEEEKKV CLPGFTGLVN
     LGNTCFMNSV IQSLSNTREL RDFFHDRSFE AEINYNNPLG TGGRLAIGFA VLLRALWKGT
     HQAFQPSKLK AIVASKASQF TGYAQHDAQE FMAFLLDGLH EDLNRIQNKP YTETVDSDGR
     PDEVVAEEAW QRHKMRNDSF IVDLFQGQYK SKLVCPVCAK VSITFDPFLY LPVPLPQKQK
     VLPIYYFARE PHSKPIKFLV SVSKENSSAS EVLESLSQSV HVKPESLRLA EVIKNRFHRV
     FLPSHSLDAV SPTDVLLCFE LLSPELAKER VVVLEVQQRP QVPSIPISKC AACQRKQQSE
     DEKLKRCTRC YRVGYCNQFC QKTHWPDHKG LCRPENIGYP FLVSVPASRL TYARLAQLLE
     GYARYSVSVF QPPFQPGRMA LESQSPGCTT LLSTSSLEAG DSEREPIQPS ELQLVTPVAE
     GDTGAHRMWP PADRGPVPST SGISSEMLAS GPMEGCSLLA GERVSRPEAA VPGYQHSRES
     VSAHTPQFFI YKIDASSREQ RLEDKGDTPL ELGDDCSLAL VWRNNERLQE FVLVASKELE
     CAEDPGSAGE AARAGHFTLD QCLNLFTRPE VLAPEEAWYC PQCKQHREAS KQLLLWRLPN
     VLIVQLKRFS FRSFIWRDKI NDLVEFPVRN LDLSKFCIGQ KEEQLPSYDL YAVINHYGGM
     IGGHYTACAR LPSDRSSQRS DVGWRLFDDS TVTTVDESQV VTRYAYVLFY RRRNSPVERP
     PRAAHAEHHP DLGPAAEAAA SQASRIWQEL EAEEEMVPEG PGPLGPWGPQ DWVGPPPRGP
     TTSDEGCLRY FVLGTVAALV ALVLNVFYPL VSQSRWR
//
